U.S. Markets closed

When a Treatment Costs $450,000 or More, It Had Better Work

Sarah Elizabeth Richards
When a Treatment Costs $450,000 or More, It Had Better Work

Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves.